Company: MYSEW
Filing Date: 2025-02-10
Form Type: 8-K
Source: 0001213900-25-011770
Chunk: 0

Company: Myseum, Inc.
Filing Date: 2025-02-10
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry into
a Material Definitive Agreement.

On February 10, 2025,
DatChat, Inc. (“we,” “us,” the “ Company” or “ DatChat”) entered into a Sales Agreement
(the “ Sales Agreement”) with The Benchmark Company, LLC (“ Benchmark”), to sell shares of our common stock, par
value $0.0001 per share, (the “ Shares”) having an aggregate sales price of up to $6,000,000, from time to time, through an
“at the market offering” program under which Benchmark will act as sales agent. The sales, if any, of the Shares made under
the Sales Agreement will be made by any method permitted by law deemed to be an “at the market offering” as defined in Rule
415 promulgated under the Securities Act of 1933, as amended.

We will pay Benchmark
a commission rate equal to 4.0% of the aggregate gross proceeds from each sale of Shares; provided however, that in the event that the
amount of Shares sold under the Sales Agreement increases to $1 million or more, then the commission rate will be reduced to 3%. In addition,
we have agreed to provide Benchmark with customary indemnification and contribution rights. We will also reimburse Benchmark for certain
specified expenses in connection with entering into the Sales Agreement. The Sales Agreement contains customary representations and warranties
and conditions to the sale of the Shares pursuant thereto.

We are not obligated
to sell any of the Shares under the Sales Agreement and may at any time suspend solicitation and offers thereunder. The offering of Shares
pursuant to the Sales Agreement will terminate on the earlier of (1) the sale, pursuant to the Sales Agreement, of Shares having
an aggregate offering price of $6,000,000 and (2) the termination of the Sales Agreement by either us or Benchmark, as permitted
therein.

The Shares will be issued
pursuant to our shelf registration statement on Form S-3 (File No. 333-268058) filed by the Company with the
SEC on October 28, 2022 and declared effective by the SEC on December 6, 2022. Concurrently herewith, we are filing a prospectus supplement
(the “ Prospectus Supplement”), dated February 10, 2025, with the U. S. Securities and Exchange Commission in connection with
the offer and sale of the Shares.

This Current Report does